OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Kris Discusses the Pemetrexed Trial Results

June 23rd 2011

Dr. Mark Kris from Memorial Sloan-Kettering Cancer Center Discusses the Pemetrexed Clincal Trial Results

Dr. West Discusses Crizotinib in ALK-NSCLC Trial Results

June 23rd 2011

Dr. Jack West from the Swedish Cancer Institute Discusses Crizotinib in ALK-NSCLC Trial Results

Dr. Hoos on a Possible Successor Drug to Ipilimumab

June 22nd 2011

Dr. Axel Hoos Medical Lead in Immunology/Oncology at Bristol-Myers Squibb on a Possible Successor Drug to Ipilimumab

Dr. Vogelzang Describes Cabozantinib's Side Effects

June 21st 2011

Dr. Nicholas Vogelzang from the Comprehensive Cancer Centers of Nevada Describes Cabozantinib's side effects

Dr. Cella on His Focus in the Axitinib and Sorafenib Trial

June 21st 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine on the Side Effect Focus of the Axitinib and Sorafenib Trial

Dr. Kris Discusses the Imatinib GIST Clinical Trial

June 20th 2011

Dr. Kris From Memorial Sloan-Kettering Cancer Center Discusses the Imatinib GIST Clinical Trial

Dr. Vogelzang on Cabozantinib Clinical Trial Results

June 20th 2011

Dr. Nicholas J. Vogelzang from the Comprehensive Cancer Centers of Nevada on Cabozantinib Clinical Trial Results

Dr. Wolchok on Patients That Had to Stop Treatment Early

June 20th 2011

Dr. Jedd D. Wolchok From Memorial Sloan-Kettering Cancer Center on Patients That Had to Stop Treatment Early

Dr. Paz-Ares Discusses the Use of Pemetrexed for NSCLC

June 17th 2011

Dr. Paz-Ares From Seville University Hospital Discusses the Use of Pemetrexed for NSCLC

Dr. Cella Discusses Axitinib and Sorafenib Axis Trial

June 17th 2011

Dr. Cella From Northwestern University Feinberg School of Medicine Discusses Axitinib and Sorafenib Axis Trial

Dr. Wolchok Explains the Future of Ipilimumab

June 17th 2011

Dr. Wolchok From Memorial Sloan-Kettering Cancer Center Explains the Future of Ipilimumab

Dr. Vogelzang on XL184's Effect on Bone Metastases

June 16th 2011

Dr. Vogelzang From the Comprehensive Cancer Centers of Nevada on XL184's Effect on Bone Metastases.

Dr. Wolchok Describes Candidates for Ipilimumab

June 16th 2011

Dr. Wolchok from Memorial Sloan-Kettering Cancer Center Describes Candidates for Ipilimumab

Dr. Chapman on Vemurafenib Combination Therapies

June 16th 2011

Dr. Chapman from Memorial Sloan-Kettering Cancer Center on Vemurafenib Combination Therapies

Dr. Hoos Discusses Key Points of the Ipilimumab Trial

June 15th 2011

Dr. Hoos From Bristol-Myers Squibb Discusses Key Points of the Ipilimumab Trial

Dr. Chapman Describes Recent Melanoma Advances

June 15th 2011

Dr. Chapman From Memorial Sloan-Kettering Cancer Center Describes Recent Melanoma Advances

Dr. Virgo Shares the Results of the PCP/MO Barriers Study

June 14th 2011

Dr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study

Dr. Kris Discusses Methotrexate in ALL

June 14th 2011

Dr Kris From Memorial Sloan-Kettering Cancer Center Discusses Methotrexate in Acute Lymphocytic Leukemia

Dr. Paz-Ares Discusses Pemetrexed Clinical Trial

June 13th 2011

Dr Paz-Ares from Seville University Hospital Discusses Pemetrexed Clinical Trial

Dr. Chapman Describes the Vemurafenib Clinical Trial

June 10th 2011

Dr. Chapman From Memorial Sloan-Kettering Describes the Vemurafenib Clinical Trial